Standard Glass Lining Share Price Target 2025, 2026, 2030, 2040, 2050
Standard Glass Lining Technology Limited was founded in September 2012. It manufactures equipment for India’s pharmaceutical and chemical industries. The company offers services such as designing, building, assembling, installing, and setting up and helping manufacturers with operating guidelines.
Its products are important for manufacturing, including reaction systems, storage tanks, separation and drying systems, and plant engineering services. The company has factories in Hyderabad and sales offices across India.
What is Standard Glass Lining Technology Ltd?
Contents
- 1 What is Standard Glass Lining Technology Ltd?
- 2 share price Target Tomorrow
- 3 Standard Glass Lining share price Target 2025
- 4 Standard Glass Lining share price Target 2026
- 5 Standard Glass Lining share price Target 2030
- 6 share price Target 2040
- 7 share price Target 2050
- 8 Should I buy Standard Glass Lining stock?
- 9 Standard Glass Lining Ltd earning results
- 10 Peers and Comparison
- 11 Is Standard Glass Lining stock good to buy? (Bull case & bear case)
- 12 Conclusion
- 13 FAQs
Standard Glass Lining Technology Limited was established in September 2012, It generally makes equipment for the pharmaceutical and chemical industries. The company offers designing, building, assembling, installing, and providing product user guides. Its products include reaction systems, storage tanks, separation and drying systems, and plant engineering services. The company has multiple factories in Hyderabad and sales offices in many parts of India.
This company is known for its modern manufacturing and wide range of products. By September 2024, the company was making over 65 high-quality products for the pharmaceutical and chemical industries. The company uses advanced technologies like 3D CAD design, robotic welding, and CNC machines to ensure high-quality products and efficient work. With these strengths, the stock has good potential for short-term growth as the company meets the growing demand in its industry.
Day | Minimum Price (Rs) | Maximum Price (Rs) |
Tomorrow | 140 | 210 |
The company is a well-known choice for glass-lined equipment in India’s pharma and chemical industries. It has continuously increased its income and profits over time. Based on expected earnings for FY25, the stock seems reasonably priced. Reducing debt and future growth plans are likely to boost its profits. This stock could be a good option for medium to long-term investors. In 2025, its stock price target would be ₹315, as per our analysis.
By our analysis, its stock price would be between ₹140 to ₹315 in 2025.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2025 | 140 | 315 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 140 | 230 |
February | 150 | 220 |
March | 168 | 208 |
April | 180 | 200 |
May | 182 | 197 |
June | 190 | 218 |
July | 210 | 230 |
August | 219 | 250 |
September | 238 | 275 |
October | 261 | 280 |
November | 272 | 293 |
December | 288 | 315 |
Based on revenue in fiscal 2024, This company is one of the top five companies in India making specialized engineering equipment for the pharmaceutical and chemical industries. The company do design and engineering to manufacturing, assembly, installation, and setting up. It also helps manufacturers with operating procedures. Its products are key to making pharmaceutical and chemical products, including reaction systems, storage, separation, and drying systems, as well as plant engineering and related services. If you look at its finances then it has the potential to give you good returns. By 2026, its stock price target would be ₹430 as per our analysis.
By our analysis, its stock price would be between ₹288 to ₹430 in 2026.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2026 | 288 | 430 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 288 | 297 |
February | 294 | 312 |
March | 300 | 326 |
April | 318 | 348 |
May | 329 | 360 |
June | 350 | 370 |
July | 359 | 378 |
August | 365 | 388 |
September | 373 | 397 |
October | 380 | 410 |
November | 396 | 430 |
December | 425 | 430 |
The company is a top maker of glass-lined, stainless steel, and nickel alloy equipment. It also supplies PTFE-lined pipelines and fittings in India. The company makes all the important equipment needed for making active pharmaceutical ingredients i.e. API, and fine chemical products. In the last 10 years, it has delivered over 11,000 products. Its brand value increasing over time, so by 2030, its stock price target will be ₹880 as per our prediction.
Its stock price would be between ₹610 to ₹880 in 2030, as per our analysis.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2030 | 710 | 880 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 710 | 728 |
February | 719 | 738 |
March | 726 | 745 |
April | 733 | 754 |
May | 745 | 768 |
June | 755 | 782 |
July | 770 | 797 |
August | 790 | 821 |
September | 810 | 838 |
October | 832 | 855 |
November | 846 | 863 |
December | 856 | 880 |
The company provides services for industries like pharmaceuticals, chemicals, food and beverage, biotechnology, and fertilizers. It customizes products based on customer needs and offers complete automated systems to improve processes like distillation, solvent recovery, and gas mixing. It serves a wide range of customers, including companies in pharmaceuticals, chemicals, paints, biotechnology, and food. Investors are attracted to its market presence and have a strong feeling that it is a good stock to invest in. By 2040, its stock price target would be ₹1800 as per our expert’s prediction.
As per our expert, its stock price would be between ₹1620 to ₹1800 in 2040.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2040 | 1620 | 1800 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 1620 | 1638 |
February | 1630 | 1657 |
March | 1648 | 1673 |
April | 1660 | 1688 |
May | 1678 | 1698 |
June | 1690 | 1718 |
July | 1709 | 1732 |
August | 1729 | 1760 |
September | 1749 | 1788 |
October | 1765 | 1790 |
November | 1760 | 1789 |
December | 1778 | 1800 |
The company serves many well-known customers in pharmaceuticals, food, and chemicals. It has many manufacturing facilities in Hyderabad, a major centre for drug production in India. Partnerships with HHV Pumps, Asahi Glass, and GL Hakko have helped the company strengthen its position in the Glass Lining and Vacuum Pumps markets, boosting its growth in India. By 2050, our experts predicted its stock price target would be ₹2940.
By 2050, its stock price will be between ₹2634 to ₹2940 as per our expert’s prediction.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2050 | 2634 | 2940 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 2634 | 2660 |
February | 2647 | 2688 |
March | 2670 | 2697 |
April | 2689 | 2732 |
May | 2711 | 2755 |
June | 2740 | 2790 |
July | 2776 | 2832 |
August | 2810 | 2856 |
September | 2840 | 2880 |
October | 2870 | 2907 |
November | 2890 | 2930 |
December | 2925 | 2940 |
Should I buy Standard Glass Lining stock?
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2025 | 140 | 315 |
2026 | 288 | 430 |
2030 | 710 | 880 |
2040 | 1620 | 1800 |
2050 | 2634 | 2940 |
The company has a strong market position, uses advanced technology, and serves industries like pharmaceuticals and chemicals. It has shown continuous financial growth and has partnerships to support its expansion. Its stock is expected to grow in the coming years, as it registered a good profit from its business each year.
Standard Glass Lining Ltd earning results
Mar 2022 | Mar 2023 | Mar 2024 | |
Sales + | 240 | 498 | 544 |
Expenses + | 200 | 412 | 449 |
Operating Profit | 40 | 86 | 95 |
OPM % | 17% | 17% | 17% |
Other Income + | 1 | 2 | 6 |
Interest | 4 | 9 | 12 |
Depreciation | 4 | 8 | 9 |
Profit before tax | 34 | 72 | 80 |
Tax % | 26% | 26% | 25% |
Net Profit + | 25 | 53 | 60 |
EPS in Rs | 5,030.00 | 10,684.00 | 11,676.00 |
Dividend Payout % | 0% | 0% | 0% |
Peers and Comparison
Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | ROCE % |
Jyoti CNC Auto. | 1365.95 | 113.18 | 31064.86 | 0.00 | 21.22 |
Jupiter Wagons | 481.00 | 55.87 | 20418.36 | 0.21 | 31.67 |
Action Const.Eq. | 1435.25 | 46.74 | 17091.42 | 0.14 | 42.30 |
Titagarh Rail | 1108.90 | 49.10 | 14933.97 | 0.07 | 24.97 |
Praj Industries | 799.50 | 52.82 | 14695.86 | 0.75 | 29.29 |
Elecon Engg.Co | 605.75 | 38.28 | 13593.03 | 0.25 | 31.32 |
Lloyds Engineeri | 87.78 | 104.77 | 10202.10 | 0.23 | 28.33 |
Standard Glass | 47.84 | 2792.88 | 23.61 | ||
Median: 63 Co. | 488.3 | 41.59 | 636.67 | 0.15 | 21.22 |
Is Standard Glass Lining stock good to buy? (Bull case & bear case)
Bull Case:
- The leading maker of glass-lined, stainless steel, and nickel alloy equipment.
- Creates custom services for industries like pharmaceuticals, chemicals, food, and beverages.
- Supplied over 11,000 products in the last 10 years, meeting many industry needs.
- Strong partnerships with HHV Pumps and GL Hakko to improve products and grow market share.
- Uses advanced technologies like CNC plasma, laser cutting, and welding systems.
- Makes stainless steel glass-lined reactors in-house, up to 10KL capacity.
- Ready to grow as demand increases in the pharmaceutical and chemical industries.
Bear Case:
- It may face problems if its factories are not fully utilized.
- Working capital days have increased from 163 days to 256 days
- It has financial risks from guaranteeing loans for its subsidiaries, which could lead to extra costs.
- Raw material price changes can affect costs, and the company has limited ability to pass these costs to customers.
- Relies mostly on its factories in Telangana, which could face risks from political changes or natural disasters.
Conclusion
This is a strong company in India’s pharmaceutical and chemical equipment industry. It uses advanced technology, offers a wide range of products, and has a good market presence. The company’s steady financial growth and partnerships make it a good choice for long-term success. On the other side, there are some risks, like depending too much on certain industries, changes in raw material prices, and relying on factories in Telangana. This stock could be a good option. for medium—to long-term investors.